Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-site, Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Standard of Care (SOC) Plus Famotidine vs SOC Plus Placebo for the Treatment of COVID-19 in Hospitalized Adults

NCT04370262 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT04370262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04370262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-site, Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Standard of Care (SOC) Plus Famotidine vs SOC Plus Placebo for the Treatment of COVID-19 in Hospitalized Adults
Lead sponsor
Northwell Health
Phase
Phase 3
Overall status
Completed
Start date
April 7, 2020
Completion date
September 7, 2020
Enrollment
233 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19